GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
Offering a combination of improved imaging technology and artificial intelligence (AI) tools, GE HealthCare showcased the Revolution Vibe computed tomography (CT) system at the recent American College of Cardiology (ACC) conference.
A prominent feature with the Revolution Vibe CT platform is Unlimited One-Beat Cardiac imaging, which bolsters the quality of low-dose images of the heart for patients with conditions including heavily calcified coronaries, in-stent restenosis, and atrial fibrillation, according to GE HealthCare.
Unveiled at the recent American College of Cardiology (ACC) conference, the Revolution Vibe computed tomography (CT) system provides artificial intelligence (AI) tools and enhanced low-dose imaging capability to facilitate improved cardiac imaging workflows and diagnostic clarity for patients with complex conditions. (Photo courtesy of GE HealthCare.)
The company added that another key aspect of the Revolution Vibe system is AI-enabled protocol selection and patient positioning through the Effortless Cardiac Workflow feature. Other benefits of the CT system include the availability of motion-free images with SnapShot Freeze 2 and bolstered CT scan quality with the TrueFidelity DL technology, according to GE HealthCare.
"Expanding access to CCTA is crucial for managing the rising prevalence of CVD, ensuring timely and accurate diagnoses for a larger patient population,” shares Jean-Luc Procaccini, the president and CEO of molecular imaging and computed tomography at GE HealthCare. “Our introduction of Revolution Vibe underscores our commitment to this mission. The system is designed to encourage the broader adoption of and access to cardiac imaging, combining advanced technology with AI-powered solutions to deliver fast, accurate diagnoses and a more comfortable patient experience.”
GE HealthCare noted that the Revolution Vibe CT system is pending 510(k) clearance with the Food and Drug Administration (FDA).
Recent Videos
Related Content
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Article
Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Article
Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Article
Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
